Decades of translational research have established the value of drug delivery and device innovation for the advance of new pharmaceutical, biological and viral therapeutic and prophylactic products. Transformative technologies have been used to enhance product attributes impacting efficacy and tolerability, such as drug absorption, distribution, stability and clearance. Delivery- or device-enabled commercial product examples abound, from oral and injectable dosages to ophthalmic, inhaled, transdermal and implanted products.  Nonetheless, as drug developers pursue more personalized medicines and biological targets of greater complexity, new delivery challenges have emerged that compel next-generation innovations, particularly for biologic, cellular and gene therapies. Technologies that improve intracellular drug delivery, oral absorption of biomolecules, local/ targeted drug delivery or the overall patient experience are currently of great interest. In this talk, I will share emerging research exemplifying such opportunities.<br/>

Next generation drug delivery and device opportunities for product development

Macromolecular Chemistry: The Second Century

[Author Benefits](https://scimeetings.acs.org/?utm_source=pubs_content_marketing&utm_medium=website&utm_campaign=0320_MCF_NPI_Launch_Spring_Homepage&ref=pubs_content_marketing)

[How to use SciMeetings](https://storage.googleapis.com/dl.morressier.com/acs/SciMeetings-ACSSpring2020-HowToGuide_M3020-Final.pdf)

[Frequently Asked Questions](https://storage.googleapis.com/dl.morressier.com/acs/SciMtng_ACSNMSp2020_FAQ_M3120_Final.pdf)

ACS Spring 2020 National Meeting & Expo

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.